1456907-40-6
1456907-40-6
Chemical Structure
NCD38 TFA
- CAS. Nr.: 1456907-40-6
- Formula:C37H37ClF3N3O4
- Molecular Weight:680.16
IUPAC Name: N-((S)-1-((3-chlorobenzyl)amino)-1-oxo-6-(((1R,2S)-2-phenylcyclopropyl)amino)hexan-2-yl)-[1,1'-biphenyl]-4-carboxamide 2,2,2-trifluoroacetate
InChIKey: SCYPMEPRSQTTPW-WBAULYFBSA-N
SMILES: O=C(C1=CC=C(C2=CC=CC=C2)C=C1)N[C@H](C(NCC3=CC=CC(Cl)=C3)=O)CCCCN[C@H]4[C@H](C5=CC=CC=C5)C4.O=C(O)C(F)(F)F
Biological Activity: NCD38 TFA is a LSD1-selective inhibitor[1][2].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
NCD38 TFA | NCD38 TFA is a LSD1-selective inhibitor. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. G R Sareddy, et al. Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway. Oncogene. 2017 Apr 27;36(17):2423-2434. [Content Brief]
- [2]. Yosuke Ota , et al. Design, synthesis and evaluation of γ-turn mimetics as LSD1-selective inhibitors. Bioorg Med Chem. 2018 Feb 1;26(3):775-785. [Content Brief]
